P, C., Y, H., R, N., A, Y., T, C., Y, G., . . . H, O. (2022). Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice. Neuro-oncology, 24(2), 259. https://doi.org/10.1093/neuonc/noab182
Chicago Style (17th ed.) CitationP, Chuntova, et al. "Novel EGFRvIII-CAR Transgenic Mice for Rigorous Preclinical Studies in Syngeneic Mice." Neuro-oncology 24, no. 2 (2022): 259. https://doi.org/10.1093/neuonc/noab182.
MLA (9th ed.) CitationP, Chuntova, et al. "Novel EGFRvIII-CAR Transgenic Mice for Rigorous Preclinical Studies in Syngeneic Mice." Neuro-oncology, vol. 24, no. 2, 2022, p. 259, https://doi.org/10.1093/neuonc/noab182.
Warning: These citations may not always be 100% accurate.